CERAMIDE AP
CERAMIDE AP is a cosmetic ingredient classified as Hair Conditioning. Also known as CAS 100403-19-8. No specific regulations have been found across 26 tracked markets.
Also Known As
- CAS Number
- 100403-19-8
Market Overview — 29 Markets
Detailed Regulations
EuropeNo restrictions
No specific restrictions for CERAMIDE AP in European Union, United Kingdom.
AmericasNo restrictions
No specific restrictions for CERAMIDE AP in United States, California, Maryland, Washington, Canada, Brazil.
East Asia & OceaniaNo restrictions
No specific restrictions for CERAMIDE AP in South Korea, Japan, Taiwan, Australia.
ASEANNo restrictions
No specific restrictions for CERAMIDE AP in Singapore, Malaysia, Thailand, Indonesia, Vietnam, Philippines.
GCCNo restrictions
No specific restrictions for CERAMIDE AP in UAE, Saudi Arabia, Qatar, Oman, Kuwait, Bahrain.
EAEUNo restrictions
No specific restrictions for CERAMIDE AP in Russia, Belarus, Kazakhstan, Armenia, Kyrgyzstan.
Frequently Asked Questions
Is CERAMIDE AP banned in any country?
CERAMIDE AP is not banned in any of the 26 markets tracked by Formpli. However, it may be subject to restrictions or conditions of use in some markets.
What are the restrictions on CERAMIDE AP in cosmetics?
CERAMIDE AP has no specific restrictions in any of the 26 markets tracked by Formpli. It can generally be used in cosmetic formulations, subject to local general cosmetic regulations.
Can I use CERAMIDE AP in cosmetics?
CERAMIDE AP has no specific regulations in any of the 26 markets tracked by Formpli. Use our free screening tool to verify your complete formula before exporting.
Screen CERAMIDE AP with your full formula
Paste your entire ingredient list and get a compliance report across 26 markets — free, no signup.
Check Ingredients FreeThis information is for reference only and does not constitute legal or regulatory advice. Regulations change — always verify with official sources and consult a regulatory specialist before exporting cosmetic products. Data sourced from EU COSING, US FDA, Health Canada, MHLW Japan, MFDS Korea, ASEAN ACD, GCC SFDA, TGA Australia, ANVISA Brazil, EAEU TR CU, and Taiwan TFDA.